The synthesis and biological activity of novel glycoprotein IIb–IIIa antagonists containing the 3, 9-diazaspiro [5.5] undecane nucleus are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the spirocyclic structures as a central template for nonpeptide RGD mimics.